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Abstract
Accumulation of the complex set of alternatively processed mRNA from the adenovirus major late transcription unit (MLTU)
is subjected to a temporal regulation involving both changes in poly (A) site choice and alternative 39 splice site usage. We
have previously shown that the adenovirus L4-33K protein functions as an alternative splicing factor involved in activating
the shift from L1-52,55K to L1-IIIa mRNA. Here we show that L4-33K specifically associates with the catalytic subunit of the
DNA-dependent protein kinase (DNA-PK) in uninfected and adenovirus-infected nuclear extracts. Further, we show that L4-
33K is highly phosphorylated by DNA-PK in vitro in a double stranded DNA-independent manner. Importantly, DNA-PK
deficient cells show an enhanced production of the L1-IIIa mRNA suggesting an inhibitory role of DNA-PK on the temporal
switch in L1 alternative RNA splicing. Moreover, we show that L4-33K also is phosphorylated by protein kinase A (PKA), and
that PKA has an enhancer effect on L4-33K-stimulated L1-IIIa splicing. Hence, we demonstrate that these kinases have
opposite effects on L4-33K function; DNA-PK as an inhibitor and PKA as an activator of L1-IIIa mRNA splicing. Taken
together, this is the first report identifying protein kinases that phosphorylate L4-33K and to suggest novel regulatory roles
for DNA-PK and PKA in adenovirus alternative RNA splicing.
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Introduction
Gene expression is a highly sophisticated molecular machinery
involving a coordinated action of multiple proteins. Human
adenovirus has been a popular model system to elucidate the
interplay between different proteins and gene expression mecha-
nisms. Indeed, adenovirus-based studies have contributed to the
general understanding of the basic gene expression mechanisms
such as gene transcription, pre-mRNA splicing and mRNA export.
Adenovirus gene expression is regulated in a highly coordinated
manner during the infectious cycle. Hence, the adenovirus genes
are sequentially expressed during the infection, producing
regulatory proteins directly following the infection (early proteins)
and structural proteins after the onset of viral genome replication
(late proteins). The collection of late proteins (at least 15 different
proteins) is encoded from a single precursor RNA (pre-mRNA)
originating from the, so-called, major late transcription unit
(MLTU). The MLTU produces five families of mRNAs with co-
terminal poly (A) sites (L1–L5, Fig. 1). Following the selection of
poly (A) site the pre-mRNA is spliced to generate a minimum of 20
alternatively spliced mRNAs, which all have a common 201
nucleotide long tripartite leader sequence at their 59 end and
diverse 39 end sequences. L1 is the only unit in MLTU producing
mRNAs both early and late after infection. The last intron in L1 is
spliced using a common 59 splice site and two alternative 39 splice
sites to produce two mRNAs, the 52,55K mRNA (proximal 39
splice site), and the IIIa mRNA (distal 39 splice site). L1 mRNA
expression is subjected to a temporal regulation. Thus, the 52,55K
mRNA is produced both early and late after infection while IIIa
mRNA is only produced late. The amazing encoding variability of
adenovirus gene expression is the result of coordinated action of
viral and host cell proteins on regulatory mechanisms occurring at
the transcriptional and post-transcriptional level [1].
The L4 unit encodes for a minimum of four mRNAs (Fig. 1), of
which two are of interest for this study. They encode for two
related proteins; L4-22K and L4-33K (Fig. 1). Work from our
group and others have shown that both proteins are key regulators
of adenovirus late gene expression by targeting pre-mRNA
splicing and MLTU transcription [2-5]. The L4-33K and L4-
22K proteins share a common N-terminus, but have unique
carboxyl-terminal domains. Both proteins have also been
suggested to perform similar functions, including packaging of
the viral genome and binding to major late promoter sequences
[6–8]. We have previously characterized the adenovirus L4-33K
protein as a novel factor regulating pre-mRNA splicing in human
cells. It functions as a key activator of the L1 alternative splicing
inducing the production of L1-IIIa mRNA in uninfected cells [2].
The splicing activation domain was mapped to the highly
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31871conserved carboxyl-terminal ds region (Fig. 1) containing a tiny
RS-repeat.
DNA-dependent protein kinase (DNA-PK) is a nuclear serine/
threonine protein kinase that belongs to the family of phospha-
tidylinositol 3-kinase-like kinases (PIKKs) [9]. Phosphorylation of
most DNA-PK substrates, like p53, is activated by linear double
stranded DNA (dsDNA) [10–12]. Biochemical studies have shown
that DNA-PK is a heterotrimeric enzyme composed of a catalytic
subunit (DNA-PKcs) and two regulatory subunits Ku86 and Ku70
[13,14]. DNA-PK is an essential protein directly involved in the
double strand break repair system (DSBR) pathway [15]. To
repair DNA double strand breaks (DSB), the Ku heterodimer
recognizes the DSB and facilitates the recruitment of DNA-PKcs
and the rest of DSBR pathway components to the injured DNA
[10–12].
Beside the involvement in DNA repair, DNA-PK has also been
suggested to have a direct role in transcription. DNA-PK interacts
with RNA polymerase II (RNAPII) and phosphorylates the C-
terminal domain (CTD) of RNAPII, thereby regulating the
transcription initiation step [16–18]. Also, DNA-PK has a
regulatory role in transcription by phosphorylating transcription
factors like Sp1, Oct-1, c-Myc, c-Jun, p53 and thereby regulating
their functions [19].
It is well established that several protein kinases are involved in
the regulation of gene transcription. This includes cAMP
dependent protein kinase (PKA), which regulates gene expression
by phosphorylating several transcription factors, including the
cAMP- responsive element (CRE) binding protein (CREB) [20]. In
the absence of cAMP, PKA is an inactive tetramer composed of a
regulatory (R) subunit dimer and two catalytic (C) subunits. PKA
subunits are encoded by four R and C subunit genes, respectively
(RIa, RIIa,R I b, RIIb,C a,C b,C c and PRKX) [21]. Specificity
in the cAMP/PKA signal transduction pathway is obtained by
tissue-specific expression and targeting the R subunits to A-kinase
anchoring proteins (AKAPs) in the cytosol and targeting of the C
subunit to C subunit-binding proteins both in the cytosol and
nucleus [22–28]. PKA is activated upon binding of four molecules
of cAMP to the R dimer, releasing the C subunits to phosphorylate
relevant substrates on serine and threonine residues in its vicinity
[29]. A proportion of the C subunits translocates to the nucleus
after activation [30,31]. In addition to gene transcription, others
and we have demonstrated that nuclear PKA regulates pre-mRNA
splicing through phosphorylation of splicing factors, such as
Serine/arginine-rich splicing factor 1 (SRSF1) and interaction
with Splicing factor arginine/serine-rich 17A (SFRS17A) [32–34].
Nuclear C subunits are inhibited and transported out of the
nucleus by the heat-stable protein kinase inhibitor (PKI) [35].
Here we show that the adenovirus L4-33K protein specifically
associates with the DNA-PKcs in uninfected and adenovirus-
infected nuclear extracts. Interestingly, the L4-33K protein is
highly phosphorylated by DNA-PK in vitro in a double stranded
DNA-independent manner. Importantly, DNA-PK deficient cells
show enhanced production of the L1-IIIa mRNA suggesting an
inhibitory role of DNA-PK on the temporal switch in L1
alternative RNA splicing. Furthermore, we show that L4-33K is
phosphorylated by PKA, and that PKA stimulates L4-33K-
induced L1-IIIa splicing. Taken together, our data suggests that
both DNA-PK and PKA phosphorylate L4-33K, regulate RNA
splicing and have opposite effects on adenovirus alternative RNA
splicing.
Results
Proteomic analysis of L4-33K interacting proteins
Adenovirus L4-33K is a multifunctional phosphoprotein
suggested to be involved in several aspects of virus gene expression
[2,4,5,36,37]. Despite the characterized functions, little is known
about the extent of the post-translational modifications of L4-33K.
To study the complexity of post-translational modifications we
transfected HEK293 cells with an L4-33K-FLAG expressing
plasmid or an empty control plasmid (Mock) and studied the
protein profile by 2D gel electrophoresis of immuno-purified
complexes. As shown in Fig. 2A, L4-33K resolved into six major
spots with approximately the same molecular weight but different
pI values. The identity of the individual spots as L4-33K was
confirmed by mass spectrometry analysis. In conclusion, this
experiment suggests that L4-33K exist in several different
isoelectric forms in cells, modifications that most likely, at least
to some extent, are due to varying levels of phosphorylation of the
protein. To validate that L4-33K is a phosphoprotein in vivo
HEK293T cells were transfected with L4-33K-FLAG and
subjected to a dephosphorylation assay. Immunoprecipitated L4-
33K-FLAG was left untreated or treated with alkaline phosphatase
(Fig. 2B). This resulted in a size reduction corresponding to
dephosphorylation of L4-33K, confirming that L4-33K is a
phosphoprotein in vivo.
Figure 1. Schematic drawing showing the spliced structure of the major late transcription unit. The tri-partite leader is labelled 59 leaders
(to the left), which is included in all mRNAs expressed from the MLTU. The arrows show the different mRNAs from each family unit (L1–L5) produced
during infection. The 52,55K mRNA from the L1 unit is the only mRNA produced early during infection. Below, the organisation of the L4-22K and L4-
33K open reading frames including the functional important ds region.
doi:10.1371/journal.pone.0031871.g001
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activities, we were interested in identifying proteins potentially
interacting with the L4-33K protein. For this purpose we used a
Glutathione-S-Transferase (GST) pull-down assay system. Purified
GST-L4-33K fusion protein was incubated with uninfected or
adenovirus-infected HeLa nuclear extracts. The nuclear proteins,
interacting with the fusion protein, were visualized by CBB
staining after SDS-PAGE (Fig. 2C) and identified by mass
spectrometry sequencing. In total we identified five proteins
specifically interacting with L4-33K under our experimental
conditions (Fig. 2C). Two of the proteins, eukaryotic translation
elongation factor 1 gamma (EEF1G) and Carbonyl reductase 1
(Cbr1), contain GST domains in their protein sequence and were
therefore regarded as potential false positive interactors [38,39].
We also identified two proteins with assigned functions in host cell
metabolism: ATP-citrate lyase and Aldolase A. Interestingly, the
L4-33K protein specifically interacted with the catalytic subunit of
the double stranded DNA-dependent protein kinase (DNA-PKcs),
both in uninfected and adenovirus infected HeLa cell nuclear
fractions (Fig. 2C). Since L4-33K is a phosphoprotein with a
suggested function as an alternative splicing factor and DNA-PK
has been connected to transcriptional regulation, which in turn is
known to regulate alternative splicing we decided to focus our
initial efforts and further explore the potential interplay between
L4-33K and DNA-PK.
L4-33K interacts with DNA-PKcs during a lytic infection
The initial identification of DNA-PKcs as a L4-33K associating
protein urged us to further validate this interaction under more
relevant in vivo conditions. For this purpose we constructed a
recombinant AdEasy virus expressing a FLAG-epitope tagged L4-
33K protein under the control of a tetracycline inducible promoter
(AdEasy-L4-33K). HEK293 cells were infected with the AdEasy-
L4-33K virus or an AdEasy-GFP control virus and nuclear
extracts prepared at 20 hpi. In this experiment we did not induce
L4-33K-FLAG expression with doxycycline, since our preliminary
experiments had shown that high level of L4-33K protein
expression was toxic to cells and resulted in an aberrant subcellular
localization of the L4-33K protein (data not shown). It should be
noted that there is a detectable level of background L4-33K
expression at 20 hpi, in the absence of inducer. This leakage most
likely results from the increase in available DNA templates for
transcription resulting from viral DNA replication. As shown in
Fig. 3, immunoprecipitation of the L4-33K-FLAG protein
revealed a specific co-purification of a high molecular weight
protein on SDS-PAGE that by mass spectrometry sequencing was
shown to be DNA-PKcs. Based on these results we conclude that
L4-33K interacts with DNA-PKcs both in vitro (Fig. 2C) and in vivo
during a lytic virus infection (Fig. 3).
L4-33K is phosphorylated by DNA-PK in a dsDNA-
independent manner
Since DNA-PK is a protein kinase we investigated whether the
L4-33K protein was a substrate for DNA-PK phosphorylation. For
this experiment we performed in vitro kinase assays with purified
L4-33K and DNA-PK. As shown in Fig. 4, L4-33K was efficiently
Figure 2. Proteomic analysis of L4-33K and interacting
proteins. A) Immuno-purified complexes from HEK293 cells transfect-
ed with either empty control plasmid (Mock) or L4-33K-Flag expressing
plasmid (L4-33K) resolved on 2D-gel electrophoresis (first dimension
pH 3–11 and second dimension 12.5% SDS-PAGE) and stained with
colloidal CBB. Numbers 1–6 point out the six spots identified by mass
spectrometry analysis as different isoelectric forms of L4-33K. B)
HEK293T cells were transfected with L4-33K-FLAG. Cell lysates were
adjusted to equal protein concentration, precleared with magnetic
beads before immunoprecipitation using anti-FLAG rabbit and mag-
netic beads. Lysates were left untreated or treated with alkaline
phosphatase (2/+ phosphatase) for 30 minutes before analysis by
immunoblotting using anti-FLAG M2. C) Pull-down with Glutathione
coated beads was performed on HeLa-nuclear extracts (HeLa-NE) or
adenovirus infected NE (Ad-NE) incubated with bacterially expressed
and purified GST-L4-33K or GST proteins (see Material and Methods).
Pulled-down proteins from HeLa NE (lanes 1 and 2) and Ad-NE (lanes 3
and 4) were separated on SDS-PAGE (Biorad, Any kD
TM) followed by
staining with colloidal CBB. All visible bands were cut out and identified
by mass spectrometry analysis to be DNA-dependent protein kinase
catalytic subunit (DNA-PKcs, 470 kDa), ATP-citrate lyase (121 kDa),
eukaryotic translation elongation factor 1 gamma (EEF1G, 50 kDa),
Aldolase A (40 kDa) and Carbonyl reductase (Cbr1, 30 kDa). The asterix
(*) indicates fusion protein degradation.
doi:10.1371/journal.pone.0031871.g002
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phosphorylation of L4-33K was not enhanced by addition of
dsDNA to the reaction mixture (lanes 5 and 6). Phosphorylation of
most DNA-PK substrates, like p53 (lanes 2 and 3), is activated by
dsDNA (see Discussion). This finding suggests that L4-33K is
phosphorylated by DNA-PK in an unusual dsDNA-independent
manner. Since the L4-33K and its relative L4-22K proteins share
a common N-terminus but have unique C-terminal ends (Fig. 1)
we decided to test if the L4-22K protein also was a substrate for
DNA-PK. As shown in Fig. 4, L4-22K was a poor substrate,
compared to L4-33K, for DNA-PK phosphorylation (lanes 5–9).
However, of some interest, the low level of L4-22K phosphory-
lation was not activated, but inhibited by addition of dsDNA (lanes
8 and 9).
The splicing enhancer function of L4-33K was previously
mapped to the ds region of L4-33K (Fig. 1), which contains a tiny
RS repeat that we previously showed is important for function [2].
Since splicing factors often are regulated by phosphorylation we
tested whether an L4-33K protein lacking the ds region, L4-
33Kds, was a substrate for DNA-PK phosphorylation. As shown in
Fig. 4 (lanes 11 and 12) L4-33Kds was a poor substrate compared
to both the wild type L4-33K (lane 5) and L4-22K (lane 8)
proteins. Surprisingly, this low level of phosphorylation was
enhanced by dsDNA (lanes 11 and 12).
DNA-PK inhibits the shift in L1 alternative RNA splicing
Since DNA-PK phosphorylated L4-33K we considered the
possibility that DNA-PK may function as a regulator of adenovirus
alternative splicing. To test this hypothesis we analyzed L1 mRNA
expression in the DNA-PKcs deficient cell line, MO59J, and its
wild type counterpart, MO59K cells. The MO59J and MO59K
cells were infected with wild-type Ad5, cytoplasmic RNA isolated
at 24 and 48 hpi and the production of the L1-52,55K (early
pattern) and L1-IIIa (late pattern) of mRNAs monitored by the S1
nuclease protection assay (Fig. 5). Interestingly, we detected a
significant increase (p,0.05, t-test) in the accumulation of the L1-
IIIa mRNA in the DNA-PK deficient cell line, MO59J (Fig. 5),
suggesting that DNA-PK has a negative effect on the switch from
the early to the late pattern of L1 alternative splicing.
L4-33K is phosphorylated by PKA
Based on previous reports that PKA phosphorylates certain
splicing factors we wanted to test if L4-33K is a PKA substrate.
For this experiment we incubated active or heat inactivated PKA
Ca1 with either purified L4-33K or L4-22K. As shown in Fig. 6,
L4-33K but not L4-22K was efficiently phosphorylated by active
PKA Ca1 in vitro (lane 1 and 3).
PKA enhances L4-33K activated L1 alternative splicing
Based on these observations and the fact that the PKA catalytic
subunit is involved in pre-mRNA splicing [32–34] we investigated
whether PKA regulates L4-33K-dependent L1 alternative splicing
in an in vivo transient co-transfection assay. For this experiment
HEK293T cells were co-transfected with a reporter plasmid
expressing the L1 gene and plasmids expressing PKA Ca1o ra
kinase inactive mutant, Ca1K73M, in the absence or presence of
an L4-33K expressing plasmid. Protein expression was confirmed
by immunoblotting using antisera detecting L4-33K or the PKA C
subunit (data not shown). The accumulation of L1 mRNAs was
analyzed by the S1 protection assay. As expected from our
previous results [2], L4-33K activated L1-IIIa mRNA accumula-
tion (Fig. 7, lanes 2–4). Transfection of Ca1 alone resulted in a
marked increase in total L1 mRNA accumulation (Fig. 7 middle
panel, compare lanes 2, 9 and 10), suggesting that PKA activates
transcription from the adenovirus MLP. However, it is noteworthy
that Ca1 transfection did not change the ratio of L1-52,55K/IIIa
mRNA accumulation (Fig. 7, lower panel, lanes 9 and 10). In
contrast, co-transfection of Ca1 together with L4-33K resulted in
both the increase in total L1 mRNA accumulation (Fig. 7, middle
panel), seen with Ca1 alone, combined with a major shift towards
accumulation of the late specific L1-IIIa mRNA (Fig. 7, lower
panel, lanes 5 and 6). These effects were not observed with the
Ca1K73M kinase inactive mutant (Fig. 7, lanes 7–8 and 11–12).
Discussion
Here we show that the adenovirus L4-33K protein specifically
associates with the nuclear DNA-PKcs in uninfected and
Figure 3. DNA-PK co-immunoprecipitates with L4-33K. Nuclear
extracts (NE) derived from AdEasy-L4-33K (33K-NE, lane 1) and AdEasy-
GFP (GFP-NE), infected HEK293 cells were Anti-FLAG M2-agarose affinity
gel purified using 36FLAG peptide-eluted preparation and analysed by
SDS-PAGE in 12% gels followed by staining with colloidal CBB. All
stained bands were cut out and analysed by mass spectrometry.
doi:10.1371/journal.pone.0031871.g003
Figure 4. L4-33K is phosphorylated by DNA-PK in a DNA-
independent manner. GST-p53 (lanes 1–3) and His-tagged L4-33K
(lanes 4–6), L4-22K (lanes 7–9) and L4-33Kds were incubated in the
presence (+) and absence (2) of DNA-PK and c
32P ATP in the presence
(+) and absence (2) of the DNA-PK activator, linear double stranded
DNA (dsDNA). Phosphorylated proteins, detected as
32P-labelled, were
resolved by SDS-PAGE in 12% gels and incorporation of radiolabelled
phosphate visualised by autoradiography (upper panel). Equal loading
of each lane was verified by CBB staining (lower panel).
doi:10.1371/journal.pone.0031871.g004
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protein is highly phosphorylated by DNA-PK in vitro in a double
stranded DNA-independent manner. Notably, DNA-PK appears
to block the early to late switch in L1-52,55K/IIIa mRNA splicing
Figure 6. Phosphorylation of L4-33K by PKA. Purified L4-33K
(lanes 1–2) and L4-22K (lanes 3–4) were incubated with active or heat-
inactivated PKA Ca1 and c-
32P-ATP in the reaction buffer. Protein
samples were analyzed by SDS-PAGE followed by CBB staining (lower
panel) and autoradiography (upper panel).
doi:10.1371/journal.pone.0031871.g006
Figure 7. Additive effect of PKA on L4-33K stimulated IIIa
splicing. HEK293T cells were left untreated (lane 1) or transfected with
reporter plasmid pTripL1,L2 (lanes 2–12) and co-transfected with L4-33K
alone (lanes 3–4) or L4-33K in conjunction with either PKA Ca1 (lanes 5–
6) or Ca1K73M (lanes 7–8). As controls HEK293T cells were transfected
with either Ca1 (lanes 9–10) or Ca1K73M (lanes 7–8) without L4-33K
(lanes 9–12). Total RNA was isolated and L1 mRNA expression measured
by S1 protection assay as described in Material and Methods. Detection
of L1-52,55K and L1-IIIa mRNAs are marked. Total L1 mRNA was
quantified and plotted as the ratio of total L1 mRNA over the total
mRNA in lane 2 (only transfected with pTripL1,L2 plasmid). The levels of
L1-52,55K and L1-IIIa mRNAs were quantified and plotted as the ratio of
L1-52,55K or L1-IIIa mRNA over total L1 mRNAs (% mRNA). Average
transcription and splicing efficiencies with standard deviations are
shown (three experiments).
doi:10.1371/journal.pone.0031871.g007
Figure 5. DNA-PK reduces the accumulation of L1-IIIa mRNA
during lytic infection. HEK293 cells (293, lanes 1 and 2), M059J cells
(DNA-PKcs negative, M059J, lanes 3–5)) and M059K cells (DNA-PKcs
positive, M059K, lanes 6–8) were infected with wild type Ad5 at 10 FFU/
cell and cytoplasmic RNA was harvested from uninfected (2)o r
infected cells at 24- and 48 h pi. L1 mRNA expression was measured by
S1 protection assay as described in Material and Methods. Detection of
L1-52,55K and L1-IIIa mRNAs are marked. The relative levels of L1-52,55K
and L1-IIIa mRNAs were quantified and plotted as the ratio of L1-52,55K
or L1-IIIa mRNA over total L1 mRNAs and normalized against the 24 h
infection of MO59K cells producing the ratio (lower panel) (five
experiments, p,0.05, t-test).
doi:10.1371/journal.pone.0031871.g005
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adenovirus MLTU alternative splicing. Further, we also show
that L4-33K is phosphorylated by PKA and that PKA has an
enhancing effect on L4-33K- activated L1-IIIa splicing. Taken
together, our results show that both DNA-PK and PKA
phosphorylate L4-33K but have distinct and opposite effects on
the early to late shift in L1 alternative splicing.
Despite the fact that L4-33K contains multiple potential
phosphorylation sites in its primary sequence, protein kinases that
phosphorylate L4-33K have previously not been characterized
[2,40]. Identification of DNA-PK and PKA as L4-33K phosphor-
ylating factors is our first successful attempts to characterize the
interplay between L4-33K phosphorylation and gene expression
regulation.
The purified L4-33K is an excellent substrate for DNA-PK in in
vitrokinase assays. In contrast, L4-22K was phosphorylated to a much
lower level suggesting that the primary DNA-PK phosphorylation
sites resides in the unique C-terminal domain of L4-33K. This
conclusion is supported by the observation that the L4-33Kds mutant
protein was not efficiently phosphorylated by DNA-PK. Taken
together, these data suggest that the ds domain contains the main
residues phosphorylated by DNA-PK. Interestingly, both L4-33K
and L4-22K are phosphorylated in the absence of dsDNA, which is
the classical activator of DNA-PK (Fig. 4). Although unusual, other
proteins are also phosphorylated by DNA-PK in the absence of
dsDNA, like the forkhead transcription factor FoxA2 and the
dysbindin-1 protein [41,42]. In fact, the nuclear receptor co-activator
thyroid hormone receptor-binding protein (TRBP) can itself activate
DNA-PK in the absence of dsDNA [43]. In addition, an RNA-
dependent phosphorylation mechanism has also been reported for
thehnRNPCproteinandthenuclearDNAhelicaseIIprotein(NDH
II) [44]. These examples point to the variety of the mechanisms
engaged in DNA-PK mediated protein phosphorylation.
L4-33K is also an excellent substrate for PKA phosphorylation
in our in vitro phosphorylation assay. A bioinformatic search
(NetPhosK server [45]) revealed that L4-33K has five putative
PKA phosphorylation sites (data not shown), of which four are
located within the unique C-terminal end. The fact that L4-33K
and L4-22K only share the N-terminus supports our observation
that L4-33K is a better PKA substrate compared to L4-22K. Out
of the four predicted PKA phosphorylation sites in the C-terminal
end, two are located within the functional ds domain. Identifica-
tion of specific phosphorylated amino acids for both DNA-PK and
PKA will need further investigation.
To this end, the specificity of L4-33K and DNA-PKcs
interaction was verified in two different experimental systems
(Figs. 2 and 3), supporting a functional association of these two
proteins. Interestingly, our affinity purification experiments did
not reveal the presence of the individual Ku proteins along with
the DNA-PKcs. One possible explanation for this observation
might be a suboptimal detection of the Ku proteins in our
experimental system. However, DNA-PKcs can also phosphory-
late substrate proteins in Ku-independent manner [13]. Therefore,
it is also possible that the Ku proteins are not essential for stable
L4-33K:DNA-PKcs complex formation. Two other adenoviral
proteins, E4-ORF3 and E4-ORF6, also associate with DNA-PK.
The linear adenovirus genome is recognized as a double-stranded
break by the MRN DNA repair system, leading to viral DNA
concatenation [46]. It has been shown that E4-ORF3 and E4-
ORF6 binding to DNA-PK is important to block this genome
concatenation [46,47].
It is intriguing that adenovirus encodes for three proteins (E4-
ORF3, E4-ORF6 and L4-33K), which all can target DNA-PK.
From this perspective it is interesting to note that all three proteins
appears to be regulators of adenovirus alternative splicing. Thus,
here we show that DNA-PK blocks the early to late switch in
adenovirus L1 alternative splicing (Fig. 5). We have previously
shown that the E4-ORF3 and E4-ORF6 proteins function as
alternative splicing factors in vivo; E4-ORF3 facilitating i-leader
exon inclusion and E4-ORF6 favoring i-leader exon skipping [48].
Considering the known functions of these proteins it is possible
that the individual proteins target DNA-PK in a temporal and
spatial manner throughout the adenovirus life cycle.
Pre-mRNA splicing occurs in a co-transcriptional manner with
splicing factors interacting with CTD in the RNAPII complex
[49]. Interestingly, DNA-PK can phosphorylate the CTD at Ser2
and Ser7, pointing to a possible indirect role of DNA-PK in
splicing [50]. Further, the regulatory Ku86 subunit of DNA-PK
has been functionally associated with RNAP II elongation
independently of DNA-PKcs [51]. In addition, Ku86 resembles
the hnRNP family of splicing factors because of its high affinity to
G-rich sequences [44]. These findings indicate a possible role for
Ku86 also in pre-mRNA processing, maybe as an alternative
splicing factor. Further experiments are needed to establish
whether Ku86 plays a role in activation of the atypical L1-IIIa
39 splice site late during infection.
We did not identify any PKA subunits in our GST-pull-down
experiments. This could be due to the low abundance of PKA C in
nuclear extracts compared to the whole cell [34]. If PKA C was
pulled down, detection would be difficult in CBB stained gels due
to several proteins of approximately the same size (40 kDa). We
therefore conducted co-immunoprecipitations with HEK293T
cells transfected with L4-33K-FLAG and PKA Ca1, but we were
not able to detect any interaction (data not shown). That PKA
does not stably interact with L4-33K was not entirely unexpected,
since a direct interaction between PKA and its substrate proteins
has been described for only a few of the over hundred
characterized PKA substrates [52].
Two of the four predicted PKA phosphorylation sites in the C-
terminal end of L4-33K are located within the functional
important ds region of L4-33K, suggesting a possible connection
between the massive effect of PKA on L4-33K activated L1-IIIa
mRNA splicing (Fig. 7), and thereby further activation of late gene
expression. This correlates well with previous reports showing that
Ad5 replication is sensitive to PKA activity, as the adenylyl cyclase
activator forskolin increase and the PKA inhibitor H-89 decrease
replication [53]. Interestingly, the same report shows that the
Adeno-associated virus (AAV2), which is dependent upon a helper
virus for a productive infection, actually inhibit adenovirus
replication by expression of the two viral proteins Rep 78 and
Rep 52 that interact with PKA C via a domain similar to that of its
endogenous nuclear inhibitor, PKI.
PKA also had a marked effect on total L1 mRNA accumulation,
suggesting a possible function of the protein kinase on MLP
transcription. Since we analyzed total RNA in this experiment
(Fig. 7) this effect most likely reflects a direct effect of PKA on
transcription, although we cannot exclude that PKA affects RNA
stability. This effect on transcription was not expected since the
MLP driving expression from the reporter plasmid does not
contain identified CRE binding sites [54]. It is known that PKA C
directly activates other transcription factors, for instance p65 Rel
of the NFkB-complex [55] and Heat shock transcription factor 1
(HSF1) [25]. Whether any of these factors regulate the MLP
remains to be investigated. Collectively, our results suggest a novel
regulatory role of PKA in L1 alternative splicing. We have
previously shown that L4-33K activates splicing via weak 39splice
sites, whether the stimulatory effect seen also is dependent on these
sequence elements or others needs to be investigated. These data
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expression; a transcriptional activation of MLP and a major
stimulatory effect on L4-33K activated L1-IIIa pre-mRNA
splicing.
Other roles for PKA during adenoviral gene expression have
been reported earlier. Already during the initial phase of the
infection PKA is involved in microtubule-mediated nuclear
targeting of the virus [56]. Furthermore, it has been demonstrated
that the E1A12S protein in fact functions as a viral AKAP that
redistributes the RIIa subunit to the nucleus where it is involved in
activation of the E2 promoter [57].
Interestingly, a link between DNA-PK and PKA has been
reported for the Epstein Barr virus (EBV) protein EBNA-LP,
which is a co-activator of EBNA-2-mediated transcription. EBNA-
LP binds to several cellular proteins, including DNA-PKcs and
homologous to AKAP95 (HA95) [58]. It was later shown that the
PKA C subunit, but not the R subunit, is associated with HA95
and EBNA-LP [24]. It is therefore suggested that that in EBV
infected cells, HA95 may function as a scaffold for EBNA-LP,
DNA-PKcs, PKA C and other proteins involved in virus-mediated
transcriptional activation. Whether something similar also is the
case during adenovirus infection remains to be elucidated. Of
relevance for our study, it is interesting to note that we have
previously shown that HA95 also is involved in regulation of
adenovirus E1A pre-mRNA splicing [34].
In light of this and previous reports on viral interaction partners
of PKA and DNA-PKcs at different stages of infection, it is
tempting to speculate that various signaling complexes consisting
of both cellular and viral proteins are important for regulation of
the adenoviral life cycle. Such complexes containing counteracting
proteins, such as DNA-PKcs and PKA Ca1, may contribute to the
diversity of the highly coordinated spatial and temporal regulation
of adenoviral gene expression.
In conclusion, this is the first report where the phosphoprotein
L4-33K is connected to any kinase and here we present two
cellular protein kinases with opposite effects on L4-33K function;
DNA-PK as an inhibitor and PKA as an activator of L1-IIIa
mRNA splicing. To the best of our knowledge this is the first
demonstration that DNA-PK has a function as a regulator of RNA
splicing. Collectively, our data suggests a novel interplay between




For bacterial expression, cDNAs of L4-33K, L4-33Kds and L4-
22K were cloned into pET24a (Novagen) expression vector
producing L4-33K and L4-22K proteins containing carboxyl-
terminal His-tags [2,3]. pGST-L4-33K plasmid was generated by
recloning L4-33K cDNA from pET24a-L4-33K [2] into pGEX-
36 plasmid (Pharmacia). Plasmid pGST-p53 was used for
expression of GST-p53 protein and has been described elsewhere
[59]. Plasmids encoding full-length PKA Ca1 and the catalytically
inactive mutant Ca1K73M in the mammalian expression vector
pEF-DEST 51 have been described previously [34,60]. Plasmid
encoding L4-33K in the mammalian expression vector pcDNA3
(Invitrogen), and the reporter plasmid, pTripL1,L2 have previ-
ously been described [2,3].
Protein purification
pGST-L4-33K and pGST-p53 were expressed in Escherichia
coli BL21 (DE3), and DH5, respectively. The expression of the
GST-L4-33K and GST proteins were induced with 0.1mM IPTG
for 3 hours at 37uC. The cells were lysed in lysis buffer (20 mM
Hepes-KOH pH 7.9, 300 mM KCl, 0.05% Triton X-100)
supplemented with protease inhibitor (Complete Mini EDTA-
free, Roche Applied sciences) and sonicated with high output
4630 s on a BioruptorH sonicator (Diagenode). Soluble lysates
were incubated with Glutathione Sepharose
TM 4B (GE Health-
care) and GST-tagged proteins were recovered by end-over-end
rotation for 2 h at 4uC. Beads were sedimented and washed 5
times 1 ml in lysis buffer. Bound proteins were eluted with Buffer
D (20 mM Hepes-KOH pH 7.9, 20% glycerol, 0.1 M KCl,
0.2 mM EDTA pH 8, 0.5 mM dithiotreitol (DTT)) supplemented
with 5 mM of reduced glutathione (Sigma). Eluates were dialyzed
against Buffer D and stored at 280uC. Protein concentration was
determined by using bovine serum albumin (BSA) as the standard
on a Coomassie Brilliant Blue (CBB) stained SDS-PAGE gel.
Recombinant his-tagged L4-33K proteins used in this study were
purified by Nickel column chromatography as previously de-
scribed [2].
GST pull-down assay
One mg of HeLa cell nuclear extract (HeLa-NE) or adenovirus
late infected nuclear extract (Ad-NE) [61] was mixed with 5 mgo f
GST or GST-L4-33K proteins in a total volume of 500 mL of 60%
Buffer D. All protein samples were cleared from precipitated
proteins by centrifugation (160606 g, 3 min at 4uC). Following
addition of 10 mL of packed Glutathione Sepharose
TM 4B samples
were incubated for 2 h with end-over-end rotation at 4uC. The
beads were washed five times with 60% Buffer D before
resuspended in Laemmli buffer [62]. The samples were heated
at 95uC for 5 min. and separated on SDS-PAGE gel (any kD
TM,
Biorad). The gels were stained with colloidal CBB. The visible
protein bands were cut out and analyzed by mass spectrometry.
Construction of a recombinant adenovirus expressing a
FLAG-tagged L4-33K protein
Transfer plasmid pShuttleTetLac-Ad5-L4-33K was constructed
by isolating the L4-33K encoding region from pcDNA3-L4-33K
plasmid [3] by digestion with Nco1, ligation of Bcl-8 linker
(CTGATCAG) and recleavage with Bcl1. The Bcl1 fragment was
cloned into the BamH1 site in the pShuttleTetLac-Bam vector
[63]. pShuttleTetLac-Ad5-L4-33K was reconstructed into a
modified recombinant AdEasy virus encoding for the Tet-ON
transcriptional activator protein inserted into the E3 region [63].
Cells, infections and transfections
HEK293 cells (ATCC) were grown on 60 mm plates in
Dulbecco’s modified eagle medium (DMEM, Invitrogen) supple-
mented with 10% newborn calf serum (NCS) and 1% penicillin-
streptomycin (PEST, Invitrogen), infected at 10 fluorescence
forming units (FFU) per cell of recombinant AdEasy-L4-33K or
AdEasy-GFP viruses. MO59K (DNA-PK positive) and MO59J
(DNA-PK negative) cells [64–66] were grown in DMEM/F12
media (Invitrogen) supplemented with 10% foetal calf serum and
1% PEST. The MO59K and MO59J cells were infected at 10
FFU/cell of wild type Ad5 virus. HEK293T cells (ATCC) were
maintained at 37uC in humidified air with 5% CO2 in RPMI 1640
(Sigma-Aldrich) supplemented with 10% foetal bovine serum
(Sigma-Aldrich), 1% non-essential amino acids (GibcoBRL), 1%
L-glutamine (Sigma-Aldrich), 1% sodium pyruvat (GibcoBRL)
and 16 PEST (Sigma-Aldrich). The cells were transfected with
Fugene HD (Roche) according to the manufacturer’s protocol.
Briefly, 6 mL Fugene HD (Roche) and a total of 2 mg DNA were
mixed in OPTIMEM, added to each well and incubated for
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with the pTripL1,L2 reporter plasmid (0.8 mg) and pcDNA3-L4-
33K (0.1–0.6 mg) and/or pEF-DEST 51 Ca1 (0.1–0.6 mg)/pEF-
DEST 51 Ca1K73M (0.1–0.6 mg)/pEF-DEST 51 empty vector.
For the L4-33K dephosphorylation assay, the cells were
transfected with 2 mg pcDNA3-L4-33K. For immunoprecipitation
and 2D-gel analysis subconfluent HEK293 cells (ATCC) were
transfected using the calcium phosphate co-precipitation method
[67]. For 150-mm plates a total of 25 mg of DNA was used.
Small-scale nuclear extract preparation
HEK293 cells (ATCC) were grown on four 150 mm plates in
DMEM (Invitrogen) supplemented with 10% NCS and 1% PEST,
infected at 10 FFU/cell of recombinant AdEasy-L4-33K or
AdEasy-GFP virus. Nuclear extract was prepared 20 hpi by,
resuspending cell pellets in 36 packed cell volume Buffer A
(10 mM Hepes-KOH pH 7.9, 1.5mM MgCl2, 10 mM KCl,
0.5 mM DTT). After 10 minutes of cell swelling, the lysates were
homogenized using a 7 mL dounce homogenizer with a tight
pestle until approximately 90% of the cells were lysed. Nuclei were
separated by centrifugation, resuspended in 16 packed nuclei
volume Buffer C (20 mM Hepes-KOH pH 7.9, 25% (v/v)
glycerol, 600 mM KCl, 0.2 mM EDTA pH 8, 0.5 mM DTT)
and further homogenized with 10 strokes through a 23G needle.
Finally, the nuclear lysates were incubated for 30 minutes with
gentle mixing every 5 min. Nuclear extract was cleared by
centrifugation and dialysed against Buffer D using 7 kDa cut off
cups.
Immunoprecipitation
NE was diluted to a final concentration of 60% Buffer D in a
total volume of 1 mL and pre-cleared by incubation with
SepharoseH CL-4B (GE Healthcare) and end-over-end rotation
for 1 h at 4uC. Pre-cleared extracts were incubated at 30uC for
5 min before 20 mL of packed anti-FLAGH M2 affinity gel (Sigma)
was added and incubation continued for 2 h by end-over-end
rotation at 4uC. Beads were sedimented on ice for 25 min and
washed four times with 60% Buffer D. Bound proteins were eluted
with 150 ng/mL3 6FLAG peptide (Sigma) in TBS (50 mM Tris-
Cl, 150 mM NaCl, pH 7.5) by gently shaking the tubes for 1 h at
4uC. The eluates were mixed with Laemmli buffer, incubated
96uC for 5 min and analyzed on 12% SDS-PAGE. Gels were
stained with colloidal CBB and bands were cut out and analyzed
by mass spectrometry.
Immunoprecipitation and 2D-gel analysis
Forty hours post transfection, cells were washed in PBS and
lysed with IsoB-NP40 (10 mM Tris-HCl [pH 7.9], 0.15 M NaCl,
1.5 mM MgCl2, 0.5% Nonidet P-40) supplemented with protease
inhibitor complete mini EDTA-free [Roche]. The lysates were
cleared by centrifugation, adjusted to equal protein concentration,
and incubated with anti-FLAGH M2 affinity gel (Sigma) for 2 h at
4uC. Beads were collected by sedimentation for 20 min on ice and
washed 3 times with IsoB-NP40. Bound proteins were eluted with
150 ng/mL3 6FLAG peptide (Sigma) in TBS by gently shaking
the tubes for 4 h at 4uC. Eluted proteins were precipitated by
addition of 8 volumes of acetone. Proteins were collected by
centrifugation and mixed with Laemmli buffer, incubated 96uC
for 5 min and analyzed by 2D-gel electrophoresis by first
dimension separation between pH 3–11, and second dimension
separation on 12.5% SDS-PAGE gel. Gels were stained with
colloidal CBB and bands were cut out and analyzed by mass
spectrometry.
S1 protection assay
Cytoplasmic or total RNA (Rneasy kit, Qiagen) was harvested
24 h post infection or transfection as previously described [2] or
according to the manufacturers instructions. Five mg of RNA was
used for the S1 analysis with an L1 probe. Conditions and
preparation of the DNA probe was as previously described [3].
The statistical analysis was performed with paired student’s t-test
in Prism GraphPad.
In vitro phosphorylation
The DNA-PK kinase assay was performed according to the
manufacturers instructions (Promega) but omitting EGTA in the
reaction buffer. Briefly, 0.3–0.5 mg of substrate proteins were
mixed with reaction buffer resulting in the final concentration of
50 mM Hepes-KOH pH 7.9, 0.1 M KCl, 10 mM MgCl2,
1m MD T T ,0 . 1m ME D T Ap H8 ,0 . 2m MA T P ,8 0mg/mL
BSA, 2 mCi of c
32P-ATP and when noted 10 mg/mL linear
double-stranded DNA (dsDNA; HpaII cleaved and phenol-
chloroform purified pUC19 (Fermentas) plasmid DNA). All
components, except DNA-PK, wer em i x e da n di n c u b a t e d3m i n
at 30uC before 10 U of DNA-PK was added and the reaction
further incubated for 10 min at 30uC. Reactions were stopped
by addition of Laemmli buffer, incubated at 95uCf o r5m i n
before proteins were separated on 12% SDS-PAGE gel,
followed by CBB staining. The incorporation of c
32P-ATP
was analyzed by PhosphorImager (BioRad) scanning. PKA in
vitro phosphorylation assay was performed as previously
described [34]. Briefly, 2.5 ng active or heat-inactivated
(10 minutes at 70uC) PKA Ca1 (Invitrogen) were mixed with
in vitro phosphorylation buffer (10 mM potassium phosphate
pH 7.4, 1 mM EDTA, 10 mM magnesium acetate and 1 mCi
c
32P-ATP). 0.25 mg purified L4-33K or L4-22K was added to a
total volume of 20 ml. The reactions were incubated at 30uCf o r
30 minutes on slushy ice for one hour and stopped by adding
SDS loading dye and boiled 5 minutes. The proteins were
resolved by SDS-PAGE and analyzed by CBB staining and
autoradiography.
Dephosphorylation assay
Twenty-four hours after transfection, cells were washed in PBS
and lysed by sonication in IP buffer (150 mM NaCl, 50 mM Tris
pH 7.5, 0.5% Triton X-100, 16 protease inhibitor cocktail
(Sigma), 1 mM PMSF and 1 mM Na3VO4). The lysates were
cleared by centrifugation and adjusted to equal protein concen-
tration (2 mg protein/ml) by the Bradford method (BioRad). The
lysates were precleared with Dynabeads Protein G (Invitrogen,
1:10) and incubated over night at 4uC with 2.5 mg rabbit anti-
FLAG antibody (Sigma). Dynabeads Protein G (1:10) were added
and incubated for 1 hour at 4uC. The samples were washed three
times with IP buffer. The dephosphorylation method was done as
previously described [68]. Briefly, the magnetic Dynabeads were
added to 100 units of alkaline phosphatase (Sigma) in 5 mM Tris
pH 7.9, 10 mM NaCl, 1 mM MgCl2 and 0.1 mM DTT and
treated for 30 minutes at 30uC or left untreated on ice. Reaction
was stopped by addition of SDS loading dye and boiled for
5 minutes before proteins were separated by SDS-PAGE (15%)
and transferred to PVDF membranes. Immunoreactive proteins
were detected by anti-FLAG M2 (Sigma, 1:1000).
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